LONDON (Reuters) -Trump administration cuts across federal health agencies have sent shivers through a biotech industry ...

"It's a perilous time for small- and mid-cap biotech companies and this will have knock ... on a COVID vaccine from Novavax, but gave a green light to a pre-filled syringe version of Argenx ...

especially for companies with innovative therapeutic approaches. Competitive pressures, patent news, and mergers and acquisitions also factor into the complex dynamics of biotech stock volatility.

There are still biotech companies hiring, but the openings tend to be highly ... There may be more churn before recovery. While a few green shoots are visible in investor sentiment and early-stage ...

They invested millions in cannabis testing equipment that allegedly couldn't pass a basic test itself. Now a slew of labs are ...

Afeyan’s venture creation firm, Flagship Pioneering, continues to launch groundbreaking biotech companies. His recent focus on using ... chemical production have opened up new possibilities in green ...

It examines European patent applications, which allow companies and researchers to protect their inventions in up to 45 countries. Biotech-related patents (225 ... the EPO has noted a general ...

Delve into the landscape of biotech companies developing treatments for HIV and find out if we are getting closer to a cure.